The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Salivation

  • Side effects of neostigmine included abdominal pain, excess salivation, and vomiting [1].
  • Administered either intraperitoneally or orally, CP-96,345 produced dose-dependent inhibition of the sialogogic response elicited by substance P, with a median effective dose of 12-24 mumol/kg (5-10 mg/kg) of body weight, but had no effect on acetylcholine-stimulated salivation [2].
  • Pretreatment with the CRF-R1 antagonist significantly attenuated several behavioral signs of naltrexone-induced morphine withdrawal, including writhing, chewing, weight loss, lacrimation, salivation, and irritability, measured during the first hour of withdrawal [3].
  • Male and female rats of two lines psychogenetically selected for bipolar extremes in shuttle box avoidance were evaluated for tremor, salivation, chromodacryoorhea, and hypothermia following treatment with the muscarinic cholinergic agonist oxotremorine [4].
  • DL-308, similarly to thioridazine, had effects consistent with an alpha-adrenolytic action; both drugs caused miosis, hypotension and a decrease in salivation [5].

Psychiatry related information on Salivation


High impact information on Salivation


Chemical compound and disease context of Salivation


Biological context of Salivation


Anatomical context of Salivation


Associations of Salivation with chemical compounds


Gene context of Salivation


Analytical, diagnostic and therapeutic context of Salivation


  1. Neostigmine for the treatment of acute colonic pseudo-obstruction. Ponec, R.J., Saunders, M.D., Kimmey, M.B. N. Engl. J. Med. (1999) [Pubmed]
  2. Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats. Snider, R.M., Longo, K.P., Drozda, S.E., Lowe, J.A., Leeman, S.E. Proc. Natl. Acad. Sci. U.S.A. (1991) [Pubmed]
  3. Role of corticotropin-releasing factor receptor-1 in opiate withdrawal. Iredale, P.A., Alvaro, J.D., Lee, Y., Terwilliger, R., Chen, Y.L., Duman, R.S. J. Neurochem. (2000) [Pubmed]
  4. Differential response to cholinergic stimulation in psychogenitically selected rat lines. Martin, J.R., Driscoll, P., Gentsch, C. Psychopharmacology (Berl.) (1984) [Pubmed]
  5. The comparison of the effects of DL-308, a potential new neuroleptic agent, and thioridazine on some psychological and physiological functions in healthy volunteers. Szabadi, E., Bradshaw, C.M., Gaszner, P. Psychopharmacology (Berl.) (1980) [Pubmed]
  6. Acute and long-term effects of thyrotropin releasing hormone on behavior mediated by dopaminergic and cholinergic activities in mice. Ushijima, I., Yamada, K., Furukawa, T. Psychopharmacology (Berl.) (1984) [Pubmed]
  7. Opposite effects of naloxone on substance P-induced changes in brain DOPA synthesis and in locomotor activity in rats. Garcia-Sevilla, J.A., Magnusson, T., Carlsson, A. J. Neural Transm. (1979) [Pubmed]
  8. Associations between side effects of nemonapride and plasma concentrations of the drug and prolactin. Kondo, T., Ishida, M., Tokinaga, N., Mihara, K., Yasui-Furukori, N., Ono, S., Kaneko, S. Prog. Neuropsychopharmacol. Biol. Psychiatry (2002) [Pubmed]
  9. Early (preweanling) recognition of alcohol's orosensory cues resulting from acute ethanol intoxication. Molina, J.C., Chotro, G., Spear, N.E. Behavioral and neural biology. (1989) [Pubmed]
  10. Modulation of salivary secretion by acid infusion in the distal esophagus in humans. Dutta, S.K., Matossian, H.B., Meirowitz, R.F., Vaeth, J. Gastroenterology (1992) [Pubmed]
  11. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Kane, J.M., Marder, S.R., Schooler, N.R., Wirshing, W.C., Umbricht, D., Baker, R.W., Wirshing, D.A., Safferman, A., Ganguli, R., McMeniman, M., Borenstein, M. Arch. Gen. Psychiatry (2001) [Pubmed]
  12. Hyperalgesia induced in the rat by the amino-terminal octapeptide of nerve growth factor. Taiwo, Y.O., Levine, J.D., Burch, R.M., Woo, J.E., Mobley, W.C. Proc. Natl. Acad. Sci. U.S.A. (1991) [Pubmed]
  13. Impaired salivary gland secretory function following the induction of rapid, synchronous vitamin A deficiency in rats. Anzano, M.A., Lamb, A.J., Olson, J.A. J. Nutr. (1981) [Pubmed]
  14. Pulmonary pharmacology of a novel, smooth muscle-selective muscarinic antagonist in vivo. Howell, R.E., Laemont, K.D., Kovalsky, M.P., Lowe, V.C., Waid, P.P., Kinnier, W.J., Noronha-Blob, L. J. Pharmacol. Exp. Ther. (1994) [Pubmed]
  15. Anorexigenic and ancillary actions of MK-212 (6-chloro-2-(1-piperazinyl)-pyrazine; CPP). Clineschmidt, B.V., Hanson, H.M., Pflueger, A.B., McGuffin, J.C. Psychopharmacology (Berl.) (1977) [Pubmed]
  16. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors. Shannon, H.E., Bymaster, F.P., Calligaro, D.O., Greenwood, B., Mitch, C.H., Sawyer, B.D., Ward, J.S., Wong, D.T., Olesen, P.H., Sheardown, M.J. J. Pharmacol. Exp. Ther. (1994) [Pubmed]
  17. Sodium valproate in the treatment of levodopa-induced dyskinesia. Price, P.A., Parkes, J.D., Marsden, C.D. J. Neurol. Neurosurg. Psychiatr. (1978) [Pubmed]
  18. Effects of oral cyclotropium bromide, hyoscine N-butylbromide and placebo on gastric emptying and antral motor activity in healthy man. Stacher, G., Bergmann, H., Havlik, E., Schmierer, G., Schneider, C. Gut (1984) [Pubmed]
  19. Effects of the cholinomimetic SDZ ENS-163 on scopolamine-induced cognitive impairment in humans. Brass, E.P., Polinsky, R., Sramek, J.J., Moore, M., Jones, D., Veroff, A.E., Wardle, T.S., Cutler, N.R. Journal of clinical psychopharmacology. (1995) [Pubmed]
  20. Bradykinin and functional vasodilatation in the salivary gland. Ferreira, S.H., Smaje, L.H. Br. J. Pharmacol. (1976) [Pubmed]
  21. Comparison of the effects of clonidine and yohimbine on spontaneous pupillary fluctuations in healthy human volunteers. Phillips, M.A., Szabadi, E., Bradshaw, C.M. Psychopharmacology (Berl.) (2000) [Pubmed]
  22. Control of alveolar surfactant in rats at rest and during prolonged hyperpnoea: pharmacological evidence for two tissue pools of surfactant. Barr, H.A., Nicholas, T.E., Power, J.H. Br. J. Pharmacol. (1988) [Pubmed]
  23. Neuropeptide K potently stimulates salivary gland secretion and potentiates substance P-induced salivation. Takeda, Y., Krause, J.E. Proc. Natl. Acad. Sci. U.S.A. (1989) [Pubmed]
  24. Potent and metabolically stable agonists for protease-activated receptor-2: evaluation of activity in multiple assay systems in vitro and in vivo. Kawabata, A., Kanke, T., Yonezawa, D., Ishiki, T., Saka, M., Kabeya, M., Sekiguchi, F., Kubo, S., Kuroda, R., Iwaki, M., Katsura, K., Plevin, R. J. Pharmacol. Exp. Ther. (2004) [Pubmed]
  25. alpha-Adrenergic regulation of secretion of mouse saliva rich in nerve growth factor. Wallace, L.J., Partlow, L.M. Proc. Natl. Acad. Sci. U.S.A. (1976) [Pubmed]
  26. Defective fluid secretion and NaCl absorption in the parotid glands of Na+/H+ exchanger-deficient mice. Park, K., Evans, R.L., Watson, G.E., Nehrke, K., Richardson, L., Bell, S.M., Schultheis, P.J., Hand, A.R., Shull, G.E., Melvin, J.E. J. Biol. Chem. (2001) [Pubmed]
  27. Excessive salivation as an anginal equivalent: a sequela to Ramsay Hunt syndrome. Cozzi, P.J., Talano, J.V. Am. J. Med. (1991) [Pubmed]
  28. Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine. Blair, J.B., Marona-Lewicka, D., Kanthasamy, A., Lucaites, V.L., Nelson, D.L., Nichols, D.E. J. Med. Chem. (1999) [Pubmed]
  29. Novel alkoxy-oxazolyl-tetrahydropyridine muscarinic cholinergic receptor antagonists. Shannon, H.E., Bymaster, F.P., Hendrix, J.C., Quimby, S.J., Mitch, C.H. Psychopharmacology (Berl.) (1995) [Pubmed]
  30. Regulation of muscarinic acetylcholine receptor function in acetylcholinesterase knockout mice. Li, B., Duysen, E.G., Volpicelli-Daley, L.A., Levey, A.I., Lockridge, O. Pharmacol. Biochem. Behav. (2003) [Pubmed]
  31. M(3) muscarinic acetylcholine receptor plays a critical role in parasympathetic control of salivation in mice. Nakamura, T., Matsui, M., Uchida, K., Futatsugi, A., Kusakawa, S., Matsumoto, N., Nakamura, K., Manabe, T., Taketo, M.M., Mikoshiba, K. J. Physiol. (Lond.) (2004) [Pubmed]
  32. Synthesis and structure-activity studies of a series of 1-oxa-2,8-diazaspiro[4.5]decan-3-ones and related compounds as M1 muscarinic agonists. Tsukamoto, S., Nagaoka, H., Igarashi, S., Wanibuchi, F., Hidaka, K., Tamura, T. Chem. Pharm. Bull. (1995) [Pubmed]
  33. Muscarinic actions of an N-methyl-N-2-bromoethylamino analog of oxotremorine (BR 401) in the mouse. Ringdahl, B., Jenden, D.J. J. Pharmacol. Exp. Ther. (1987) [Pubmed]
  34. Paradoxic reaction to lamotrigine in a child with benign focal epilepsy of childhood with centrotemporal spikes. Catania, S., Cross, H., de Sousa, C., Boyd, S. Epilepsia (1999) [Pubmed]
  35. Muscarinic receptor binding, plasma concentration and inhibition of salivation after oral administration of a novel antimuscarinic agent, solifenacin succinate in mice. Oki, T., Sato, S., Miyata, K., Yamada, S. Br. J. Pharmacol. (2005) [Pubmed]
  36. In vivo and in vitro actions of mammalian tachykinins. Holzer-Petsche, U., Schimek, E., Amann, R., Lembeck, F. Naunyn Schmiedebergs Arch. Pharmacol. (1985) [Pubmed]
  37. The mechanism of the clonidine-induced reduction in peripheral parasympathetic submaxillary salivation. Green, G.J., Wilson, H., Yates, M.S. Eur. J. Pharmacol. (1979) [Pubmed]
WikiGenes - Universities